Early diagnosis of primary nonfunction and indication for reoperation after liver transplantation

Liver Transplantation

Volumn 16, Issue 2, 2010, Pages 172-180

  Lock, Johan Friso ^a   Schwabauer, Eugen ^a   Martus, Peter ^a   Videv, Nikolay ^a   Pratschke, Johann ^a   Malinowski, Maciej ^a   Neuhaus, Peter ^a   Stockmann, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUTAMATE DEHYDROGENASE; INDOCYANINE GREEN;

ADULT; AGED; AMMONIA BLOOD LEVEL; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DONOR; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PILOT STUDY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REOPERATION; UNIVARIATE ANALYSIS;

ADULT; AGED; COLORING AGENTS; DELAYED GRAFT FUNCTION; EARLY DIAGNOSIS; FEMALE; HUMANS; INDOCYANINE GREEN; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REOPERATION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 75449118475     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21973     Document Type: Article

References (30)

1. Mor E, Klintmalm GB, Gonwa TA, Solomon H, Holman MJ, Gibbs JF, et al. The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation 1992;53:383-386.
2. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation - a multivariate analysis. Transplantation 1993;55:807-813.
3. Pokorny H, Gruenberger T, Soliman T, Rockenschaub S, Langle F, Steininger R. Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation. Transpl Int 2000;13(suppl 1):S154-S157.
4. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992;53: 957-978.
5. Burton JR Jr, Rosen HR. Diagnosis and management of allograft failure. Clin Liver Dis 2006;10:407-435.
6. Clavien PA, Camargo CA Jr, Croxford R, Langer B, Levy GA, Greig PD. Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 1994;220:109-120.
7. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6:97-106.
8. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824-828.
9. Maring JK, Klompmaker IJ, Zwaveling JH, Kranenburg K, Ten Vergert EM, Slooff MJ. Poor initial graft function after orthotopic liver transplantation: can it be predicted and does it affect outcome? An analysis of 125 adult primary transplantations. Clin Transplant 1997;11: 373-379.
10. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998; 66:302-310.
11. Gonzalez FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994;20:565-573.
12. Gao L, Ramzan I, Baker AB. Potential use of pharmacological markers to quantitatively assess liver function during liver transplantation surgery. Anaesth Intensive Care 2000;28:375-385.
13. Maring JK. Studies on Predictability of Early Graft Function After Liver Transplantation. Groningen, the Netherlands: Rijksuniversiteit; 2005.
14. Jalan R, Plevris JN, Jalan AR, Finlayson ND, Hayes PC. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 1994;58: 196-200.
15. Shaked A, Nunes FA, Olthoff KM, Lucey MR. Assessment of liver function: pre- and peritransplant evaluation. Clin Chem 1997;43:1539-1545.
16. Di Campli C, Angelini G, Armuzzi A, Nardo B, Zocco MA, Candelli M, et al. Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol 2003;15:727-732.
17. Freeman RB Jr. L-[1-13C] phenylalanine breath test for monitoring hepatic function after liver donor liver transplantation. J Breath Res 2007;1:026002.
18. Festi D, Capodicasa S, Vestito A, Mazzella G, Roda E, Vitacolonna E, et al. Breath tests with stable isotopes: have they a role in liver transplantation? Eur Rev Med Pharmacol Sci 2004;8:55-58.
19. Potter JM, Hickman PE, Henderson A, Balderson GA, Lynch SV, Strong RW. The use of the lidocaine-monoethylglycinexylidide test in the liver transplant recipient. Ther Drug Monit 1996;18:383-387.
20. Stockmann M, Lock JF, Riecke B, Heyne C, Martus P, Fricke M, et al. Prediction of postoperative outcome after hepatectomy with a new bedside test for maximal liver function capacity. Ann Surg 2009;250:119-125.
21. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003;326:41-44.
22. Yamanaka N, Okamoto E, Kato T, Fujihara S, Sasase S, Oriyama T, et al. Usefulness of monitoring the ICG retention rate as an early indicator of allograft function in liver transplantation. Transplant Proc 1992;24: 1614-1617.
23. Bruegger L, Studer P, Schmid SW, Pestel G, Reichen J, Seiler C, et al. Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. J Gastrointest Surg 2007;12:67-72.
24. Stockmann M, Malinowski M, Lock JF, Seehofer D, Neuhaus P. Factors influencing the indocyanine green (ICG) test: additional impact of acute cholestasis. Hepatogastroenterology 2009;56:734-738.
25. Hashimoto K, Miller C. The use of marginal grafts in liver transplantation. J Hepatobiliary Pancreat Surg 2008;15: 92-101.
26. Nanashima A, Pillay P, Verran DJ, Painter D, Nakasuji M, Crawford M, et al. Analysis of initial poor graft function after orthotopic liver transplantation: experience of an Australian single liver transplantation center. Transplant Proc 2002;34:1231-1235.
27. Rosen HR, Martin P, Goss J, Donovan J, Melinek J, Rudich S, et al. Significance of early aminotransferase elevation after liver transplantation. Transplantation 1998;65:68-72.
28. Pauwels S, Geubel AP, Dive C, Beckers C. Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases. Dig Dis Sci 1982;27:49-56.
29. Tugtekin I, Radermacher P, Wachter U, Barth E, Weidenbach H, Adler G, et al. Comparison between the oral and intravenous L-[1-13C]phenylalanine breath test for the assessment of liver function. Isotopes Environ Health Stud 1999;35:147-156.
30. Ewald B. Post hoc choice of cut points introduced bias to diagnostic research. J Clin Epidemiol 2006;59:798-801.